Combination therapy for Behçet uveitis.

Suppr

超能文献

作者信息

Webster Holly

机构信息

Nature Reviews Rheumatology, .

出版信息

Nat Rev Rheumatol. 2024 Nov;20(11):667. doi: 10.1038/s41584-024-01173-x.

DOI:10.1038/s41584-024-01173-x

PMID:39367241

Abstract

摘要

相似文献

Combination therapy for Behçet uveitis.

Nat Rev Rheumatol. 2024 Nov;20(11):667. doi: 10.1038/s41584-024-01173-x.

Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis.

Ocul Immunol Inflamm. 2017 Feb;25(1):71-75. doi: 10.3109/09273948.2015.1133835. Epub 2016 Feb 24.

Uveitis associated with pediatric behçet disease in the american midwest.

Am J Ophthalmol. 2008 Dec;146(6):819-27.e2. doi: 10.1016/j.ajo.2008.05.043. Epub 2008 Jul 30.

Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases.

Am J Ophthalmol. 2003 Dec;136(6):1114-9. doi: 10.1016/s0002-9394(03)00791-8.

Clinical Follow-up of Patients with Behçet Uveitis after Discontinuation of Infliximab Therapy.

Ocul Immunol Inflamm. 2022 Jan 2;30(1):203-207. doi: 10.1080/09273948.2020.1774907. Epub 2020 Aug 11.

Validity and agreement of uveitis experts in interpretation of ocular photographs for diagnosis of Behçet uveitis.

Ocul Immunol Inflamm. 2014 Dec;22(6):461-8. doi: 10.3109/09273948.2013.854393. Epub 2013 Dec 11.

[Effect of corticotherapy on interleukin-8 and -12 and nitric oxide production during Behçet and idiopathic uveitis].

J Fr Ophtalmol. 2008 Apr;31(4):387-95. doi: 10.1016/s0181-5512(08)71433-5.

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis.

Turk J Ophthalmol. 2021 Aug 27;51(4):206-211. doi: 10.4274/tjo.galenos.2020.28485.

Spectral domain optical coherence tomography as an adjunctive tool for screening Behçet uveitis.

PLoS One. 2018 Dec 11;13(12):e0208254. doi: 10.1371/journal.pone.0208254. eCollection 2018.

Classification Criteria for Behçet Disease Uveitis.

Am J Ophthalmol. 2021 Aug;228:80-88. doi: 10.1016/j.ajo.2021.03.058. Epub 2021 May 11.

本文引用的文献

Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial.

Lancet Rheumatol. 2024 Nov;6(11):e780-e790. doi: 10.1016/S2665-9913(24)00194-2. Epub 2024 Sep 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Combination therapy for Behçet uveitis.

Nat Rev Rheumatol. 2024 Nov;20(11):667. doi: 10.1038/s41584-024-01173-x.

Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis.

Ocul Immunol Inflamm. 2017 Feb;25(1):71-75. doi: 10.3109/09273948.2015.1133835. Epub 2016 Feb 24.

Uveitis associated with pediatric behçet disease in the american midwest.

Am J Ophthalmol. 2008 Dec;146(6):819-27.e2. doi: 10.1016/j.ajo.2008.05.043. Epub 2008 Jul 30.

Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases.

Am J Ophthalmol. 2003 Dec;136(6):1114-9. doi: 10.1016/s0002-9394(03)00791-8.

Clinical Follow-up of Patients with Behçet Uveitis after Discontinuation of Infliximab Therapy.

Ocul Immunol Inflamm. 2022 Jan 2;30(1):203-207. doi: 10.1080/09273948.2020.1774907. Epub 2020 Aug 11.

Validity and agreement of uveitis experts in interpretation of ocular photographs for diagnosis of Behçet uveitis.

Ocul Immunol Inflamm. 2014 Dec;22(6):461-8. doi: 10.3109/09273948.2013.854393. Epub 2013 Dec 11.

[Effect of corticotherapy on interleukin-8 and -12 and nitric oxide production during Behçet and idiopathic uveitis].

J Fr Ophtalmol. 2008 Apr;31(4):387-95. doi: 10.1016/s0181-5512(08)71433-5.

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis.

Turk J Ophthalmol. 2021 Aug 27;51(4):206-211. doi: 10.4274/tjo.galenos.2020.28485.

Spectral domain optical coherence tomography as an adjunctive tool for screening Behçet uveitis.

PLoS One. 2018 Dec 11;13(12):e0208254. doi: 10.1371/journal.pone.0208254. eCollection 2018.

Classification Criteria for Behçet Disease Uveitis.

Am J Ophthalmol. 2021 Aug;228:80-88. doi: 10.1016/j.ajo.2021.03.058. Epub 2021 May 11.

本文引用的文献

Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial.

Lancet Rheumatol. 2024 Nov;6(11):e780-e790. doi: 10.1016/S2665-9913(24)00194-2. Epub 2024 Sep 2.